Biological treatment innovation carrier, in the strategic layout of biotechnology and industrialization, in frontier fields such as clinical diagnosis and treatment, regenerative medicine, to create an internationally competitive bio-industrial system, making Shenzhen International Bio Valley an important carrier to represent the country in participating in global technology and industrial competition, and to enhance my country’s innovation capabilities and competitive advantages.
201
News link
After the establishment of Dapeng New District, it has focused on the strategic goal of building “three islands and one district” to create Shenzhen International Biovalley, innovating systems and mechanisms, accelerating the construction of scientific research carriers and the transformation of results, and promoting the development of strategic emerging industries, which has initially formed a new situation driven by technological innovation. At present, innovative institutions such as the Shenzhen National Gene Bank, the Shenzhen Institute of Biological Breeding Innovation of the Chinese Academy of Agricultural Sciences, and the Shenzhen Institute of Agricultural Genomics of the Chinese Academy of Agricultural Sciences have been gradually established to support the construction of the Bio Valley. Science and technology R&D incubation platforms such as the Life Science Industrial Park and the Marine Biology Industrial Park are rising. With the settlement of a number of world-class projects such as the team of Professor Rozman, an academician of the National Academy of Sciences, Medicine, and the Chinese Academy of Engineering, and the team of Professor Marshall, a Nobel Prize winner in medicine, the development pattern of Shenzhen’s east and west wings with “Qianhai Cooperation Zone in the west and Dapeng Biological Valley in the east” is accelerating to take shape.
Currently, the construction of the Bioguba Optical Core Startup Zone has been fully launched, 13 infrastructure projects have been started one after another, and the planning and construction of key industrial carriers such as Biohome is also accelerating. As part of the Shenzhen National Independent Innovation Demonstration Zone, the new district is working hard to implement some of the country’s pilot policies in Baguang. In accordance with the requirements of the “Shenzhen National Independent Innovation Demonstration Zone Construction Implementation Plan”, the new district has comprehensively revised the existing “1+7” talent policy, and combined with the actual conditions of the new district, it has increased support for talent introduction, training, incentives, and housing. In order for Shenzhen and Hong Kong to jointly establish the Shenzhen branch of the National Drug Evaluation Center in the Shenzhen International BioValley, the New District, together with the Municipal Foreign Affairs Office, communicated with the Hong Kong SAR government many times and reached a consensus.